Skip to main content
. 2017 Dec 28;17:902. doi: 10.1186/s12885-017-3895-z

Fig. 4.

Fig. 4

Forest plots for the comparison of ORs for OS in HCC patients with type II PVTT who received HR or TACE. Outcomes: a 1-year OS; b 3-year OS; c 5-year OS; A random effects model was used in the meta-analyses of the three outcomes